Riken Vitamin Co., Ltd. (4526.T) JPX

Currency In JPY

AD

Valuation

Market Cap84.83B
Enterprise Value71.9B
P/E Ratio12.75
PEG Ratio-0.71
Price/Sales Ratio0.91
Price/Book Ratio1.06
Enterprise/Revenue0.81
Enterprise/EBITDA6.66

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue96.3B
Revenue/Share3,369.44
Gross Profit29.77B
EBITDA11.58B
Net Income7.04B
Diluted EPS238.17

Balance Sheet

Total Cash17.91B
Total Cash/Share614.51
Total Debt7.4B
Total Debt/Equity0.09
Current Ratio3.51
Book Value Per Share2,896.67

Price History

52-Week Change8.66
52-Week High3,470
52-Week Low2,662
Moving Average 50 Days3,274.6
Moving Average 200 Days3,043.57

Statistics

Average Volume77,855
Shares Outstanding29.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate110
Trailing Annual Dividend Yield3.58
Payout Ratio0
Last Split Factor2:1
Last Split DateMarch 30, 2020
AD